Substance Use and Lifestyle-related Health Problems Among Ageing Patients in OMT and Other SUD Treatment
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Substance Use Disorders
- Sponsor
- Sorlandet Hospital HF
- Enrollment
- 548
- Locations
- 1
- Primary Endpoint
- Substance use
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
The overall aim of the study is to explore substance use, tobacco use and lifestyle-related health problems among ageing patients in Opioid Maintenance Treatment (OMT), and other SUD treatment.
The study will use already collected data from the multi-center, longitudinal, observational NorComt study (Norwegian Cohort of Patients in Opioid Maintenance Treatment and Other Drug Treatment study).
NorComt is the largest longitudinal study of SUD patients in Norway. The data consists of data from OMT and other substance use disorders (SUD) treatment (N=548).
Detailed Description
The overall aim of the study is to explore substance use, tobacco use and lifestyle-related health problems among ageing patients in Opioid Maintenance Treatment (OMT), and other SUD treatment. The study will use already collected data from the multi-center, longitudinal, observational NorComt (Norwegian Cohort of Patients in Opioid Maintenance Treatment and Other Drug Treatment) study. NorComt is the largest longitudinal study of SUD patients in Norway. The data consists of data from OMT and other substance use disorders (SUD) treatment (N=548). The present doctoral research degree project is financed by the Southern and Eastern Norway Regional Health Authority, and hosted by Sørlandet hospital in collaboration with the Norwegian Centre for Addiction Research (SERAF). Ethical approval for analysis of NorComt data and for the planned registry data linkages of NorComt data has been granted by the Norwegian Regional Ethics Committee (REK 2012/1131).
Investigators
Eligibility Criteria
Inclusion Criteria
- •Admittance to a substance use disorder treatment facility, either standardized opioid maintenance treatment (OMT) or other substance use disorder treatment (in-patient)
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Substance use
Time Frame: Approximately one year after admission to treatment (range 11 - 18 months)
Changes in substance use from baseline to follow-up. Excerpts from the European version were used to collect data on substance use. Substance use was scored for the previous 4 weeks on a 6-point response format were 0 corresponded to "No use" and 5 corresponded to "Daily use". 1 year follow-up were compared with baseline values.
Somatic complaints.
Time Frame: Approximately one year after admission to treatment (range 11 - 18 months).
Changes in somatic complaints from baseline to follow-up. A checklist containing 16 somatic complaints common among chronic drug users, including major organ systems. Responses are provided on a 0 -4 response format, with 0 corresponding to "not at all", 1 "a little", 2 "moderately", 3 "a lot", and 4 "very much".
Tobacco use
Time Frame: Approximately one year after admission to treatment (range 11 - 18 months)
Changes in tobacco use from baseline to follow-up
Secondary Outcomes
- Mental distress(Approximately one year after admission to treatment (range 11 - 18 months))
- QoL (quality of life)(Approximately one year after admission to treatment (range 11 - 18 months))